InsidersTradesSigma
围绕1.6M+份申报和43个市场的深度数据研究。跨市场监管对比、walk-forward回测、内部人画像、市场机制。
GSK’s August share-plan buys came as pharma traded unevenly, AstraZeneca stayed in focus, and GSK’s own setup kept improving.
Teleperformance insiders sold about EUR 3.9m in August. Read that cluster against AI-driven BPO pressure, CAC 40 strength, and TTEC's weaker print.